Chris Richardson

Chris Richardson has extensive work experience in the medical industry, holding various leadership roles throughout their career. Chris is currently serving as the Chief Executive Officer at SafeHeal since April 2022. Prior to this, they were the Executive Chairman of the Board of Directors at Neurolief from January 2020 to May 2022.

From May 2016 to September 2021, Chris Richardson worked as the President and CEO of Keystone Heart Ltd. In this role, they provided guidance to the board of directors, motivated employees, and drove organizational change across various departments including operations, marketing, business development, finance, and human resources.

Before joining Keystone Heart Ltd., Chris Richardson worked at Direct Flow Medical Inc. as the President International and Chief Commercial Officer from December 2014 to April 2016. Chris'sresponsibilities included overseeing international business operations and leading commercial initiatives.

From August 2008 to November 2014, Chris Richardson served as the General Manager of Evalve Inc., a subsidiary of Abbott Vascular Inc. In this role, they developed strategic plans for global marketing and business expansion, including product development, pricing strategies, and P/L forecasting.

Prior to that, Chris Richardson worked at Boston Scientific as the Area Vice President CRM from September 2004 to August 2008. Chris also held a position at Guidant as the Director of GSC Management Development from June 2003 to September 2004.

Overall, Chris Richardson's work experience demonstrates their expertise in executive leadership, strategic planning, and driving business growth in the medical industry.

Chris Richardson completed their Bachelor of Science (BS) degree in Psychology from Indiana University Bloomington in the years 1979 to 1983. Following that, from 1983 to 1985, they pursued a Bachelor of Applied Science (B.A.Sc.) in Physician Assistant from CCC PA.